APA (7th ed.) Citation

C, B. X., CR, A., J, L., JH, S., SA, B., L, K., . . . S, F. (2025). Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit. Cancer research communications, 5(9), 1631. https://doi.org/10.1158/2767-9764.CRC-25-0033

Chicago Style (17th ed.) Citation

C, Braganca Xavier, et al. "Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit." Cancer Research Communications 5, no. 9 (2025): 1631. https://doi.org/10.1158/2767-9764.CRC-25-0033.

MLA (9th ed.) Citation

C, Braganca Xavier, et al. "Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit." Cancer Research Communications, vol. 5, no. 9, 2025, p. 1631, https://doi.org/10.1158/2767-9764.CRC-25-0033.